Shareholding disclosure

EW Healthcare Partners Acquistion Fund UGP, LLC

Declared position

4.99%

Threshold

Crossed upwards

Timeline

Published

05.01.2022

Transaction

22.12.2021

Voting rights breakdown

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TALCT00024

Beneficial owner

EW Healthcare Partners Acquistion Fund UGP, LLC

Declared address

EW Healthcare Partners Acquistion Fund UGP, LLC, The Woodlands, Texas

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

EW Healthcare Partners Acquistion Fund UGP, LLC

Molecular Partners AG05.01.2022TALCT00024

Disclosure summary

EW Healthcare Partners Acquistion Fund UGP, LLC disclosed a holding in Molecular Partners AG on the acquisition side, published by SIX Exchange Regulation on 05.01.2022, at 4.99% of voting rights. Notice category: Single shareholder.

Disclosed position

4.99%

Voting rights acquired

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

EW Healthcare Partners Acquistion Fund UGP, LLC disclosed a holding in Molecular Partners AG, published on 05.01.2022.

Publication date05.01.2022

Transaction date22.12.2021

Issuing companyMolecular Partners AG

Beneficial ownerEW Healthcare Partners Acquistion Fund UGP, LLC

Declared addressEW Healthcare Partners Acquistion Fund UGP, LLC, The Woodlands, Texas

CategorySingle shareholder

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTALCT00024

Source: SIX Exchange Regulation · Publication date: 05.01.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open